mayureshraut2005's blog
Pharma Packaging GO GREEN
Submitted by Mayuresh K.Raut on Tue, 12/09/2008 - 07:31 Rexam prescription Products has become first packaging company to develop and markret a liquid prescription oval made with 100% post consumer recycled PET resin.
This package can be recycled again and again further reducing resource consumption and environmental impact.
Reference: www.newmedia.com
Chicken soup –Fights High blood pressure
Submitted by Mayuresh K.Raut on Tue, 12/09/2008 - 07:29Chicken soup may have a new role alongside medication and other medical measures in fighting high blood pressure.
Aurobindo Pharma receives final approval for Fluconazole tablets
Submitted by Mayuresh K.Raut on Wed, 12/03/2008 - 13:30Aurobindo Pharma has received final approval from USFDA to manufacture and market Fluconazole tablets 50mg, 100mg, 150mg and 200mg.Fluconazole tablet is the generic version of Pfizer’s Diflucon tablets and is indicated for the treatment of fungal infections.
Reference-www.pharmabiz.com
Seroquel XR gets USFDA Nod for bipolar disorder
Submitted by Mayuresh K.Raut on Wed, 12/03/2008 - 13:29Astrazeneca announced that the USFDA has approved once daily Seroquel XR (Quetiapine Fumarate) extended release tablets for the acute treatment of the depressive episodes associated with bipolar disorder, the manic and mixed episodes associated with bipolar treatment and the maintenance treatment of bipolar disorder as adjunctive therapy to lithium or divalproex.
Wockhardt gets USFDA nod for ceftazidime injectable
Submitted by Mayuresh K.Raut on Wed, 12/03/2008 - 13:28The Mumbai based Wockhardt has received USFDA approval to market ceftazidime injections containing 1g/vial the generic version of glaxosmithklines Fortaz.Ceftazidime is used for treating various kinds of infections.
Reference-www.pharmabiz.com
- 1 comment
- 89 reads
Watson received USFDA approval for Rapaflo
Submitted by Mayuresh K.Raut on Wed, 12/03/2008 - 13:27Watson Pharmaceuticals a leading pharmaceutical announced that USFDA has approved Rapaflo (silodosin) the companys new alpha blocker for the treatment of the signs and symptoms of benign prostatic Hyperplasia (BPH).Rapaflo is an effective selective alpha-1 adrenergic receptor antagonist.The most common side effect with Rapaflo is reduced or no semen during orgasm, dizziness, light headedness, diar
Zydus Cadila to receive WHO accredition for rabies vaccine
Submitted by Mayuresh K.Raut on Wed, 12/03/2008 - 13:26The WHO has approved Lyssavac N the purified duck Embryo Rabies Vaccine (PDEV) manufactured by Zydus Cadila, for purchase by various United Nations Agencies.Zydus Cadila becomes the first Indian Pharma company in the world and the second pharma company in world to receive the WHO accredition for rabies vaccine.
Reference-www.pharmabiz.com
FDA licences drug to prevent joint damage in children
Submitted by Mayuresh K.Raut on Wed, 12/03/2008 - 13:25The USFDA approved new use for the blood product Kogenate FS to reduce the frequency of bleeding episodes and prevent joint damage in children with the most severe form of haemophilia.Haemophilia A is a rare, herediatary bleeding disorder in which a protein needed to form blood clots, factor VIII, is missing or its level is reduced.
Reference-www.fda.gov
Inhaled vaccine for TB
Submitted by Mayuresh K.Raut on Wed, 11/26/2008 - 13:51- 2 comments
- 65 reads
Treatment to halt Alzheimer’s disease
Submitted by Mayuresh K.Raut on Wed, 11/26/2008 - 13:29The scientists at Alzheimer’s Association International Conference on Alzheimer’s disease (ICAD 2008) in Chicago revealed major breakthrough in the treatment of Alzheimer’s disease. It is the first drug to act on the tangles discovered by Dr Alois Alzheimer over a century ago.
- 3 comments
- Read more
- 83 reads

